Beate Escher

Beate Escher’s research interest focus on mode-of-action based environmental risk assessment, including methods for initial hazard screening and risk assessment of pharmaceuticals, pesticides, disinfection by-products and persistent organic pollutants with an emphasis on mixtures. A special interest is the effect assessment of transformation products and disinfection by-products. One of Escher’s goals is to close the gap between exposure and effect assessment through common approaches linking bioavailability to internal exposure and effects via understanding and modelling of toxicokinetic and toxicodynamic processes. More practically oriented aspects of her work include passive sampling and effect-based methods for water quality assessment. Further she has an interest in improving dosing methods for very hydrophobic and volatile compounds and to develop new in-vitro assays for bioaccumulation and toxicity assessment.

Lab Information

Helmholtz Centre for Environmental Research–UFZ

Research Area and Skills

Recognize this scientist’s Expertise for their contribution in your research

Mode-of-action based environmental risk assessment 1 Water Quality Assessment 1 Toxicokinetic and Toxicodynamic Processes 1

More

  • Post
  • Publication
  • Plasmid
  • Following (0)
  • Follower (2)


This guy hasn’t posted anything yet.

Hot Posts for You

Neutralizing antibodies (NAbs) are critical human immune defense mechanisms against viral infections. NAbs can bind to sites on the virus and inhibit entry of that virus into the host. It is a key parameter to evaluate COVID-19 vaccine efficacy per Guidelines from Development and ...Learn More


This 3D animation shows you how DNA is copied in a cell. It shows how both strands of the DNA helix are unzipped and copied to produce two identical DNA molecules. TranscriptDNA is a molecule made up of two strands twisted around each other in a double helix shape. Each strand is ...Learn More


IntroductionA gleam of light finally shone down on the global crisis of the prolonged battle against COVID-19, giving people hopes of preventive care and treatment in the near future by monoclonal antibodies against SARS-CoV-2. As stated the news of NIH’s phase III clinical ...Learn More


"Those who do not know history are obliged to repeat it" This famous phrase that could be from any history teacher to his suspended students has been attributed to great figures in history such as Napoleon or the philosopher George Santayana. In a modern version of it we could say ...Learn More


In recent years there is an increasing number of cytotoxic chemotherapeutic compounds with the ability to rapidly kill dividing cancer cells in preference to non-dividing healthy cells. Nevertheless, the major drawback of chemotherapy is that, in addition to damaging the cancer ...Learn More


The coronavirus pandemic caught everyone unprepared. We had to deal with the fear of an unknown virus which can be lethal for some people. And the whole world just stopped in an attempt to prevent the virus spread.Suddenly we had to adapt to a new way of living, socially isolated ...Learn More


This is the first episode of MolecularCloud Pioneer Scientist interview series. In this interview, MolecularCloud talks with Prof. Shuo Huang from Nanjing University about the recent publications of Dr. Huang’s team and the future prospect of biological nanopore technology. The ...Learn More


The increasing number of confirmed COVID-19 cases is prompting an unprecedented global effort to find a treatment for the disease. Given the fact that a new drug development could be a decade work from initial discovery to the marketplace, scientists are racing to search a cure ...Learn More


The previous article on precision medicine was focused on Pharmacogenomics as a fundamental aspect of cancer therapeutics. In this sequel, emphasis would be on the role of immuno-oncology in personalization of cancer therapy, citing anti PD therapy as an example with hypothetical ...Learn More


  1. Escher BI, Henneberger L, König M, Schlichting R, Fischer FC. Cytotoxicity Burst? Differentiating Specific from Nonspecific Effects in Tox21 in VitroReporter Gene Assays. Environ Health Perspect. 2020;128(7):77007. doi:10.1289/EHP6664

  2. Neale PA, Braun G, Brack W, et al. Assessing the Mixture Effects in In Vitro Bioassays of Chemicals Occurring in Small Agricultural Streams during Rain Events. Environ Sci Technol. 2020;54(13):8280-8290. doi:10.1021/acs.est.0c02235

  3. Huchthausen J, Mühlenbrink M, König M, Escher BI, Henneberger L. Experimental Exposure Assessment of Ionizable Organic Chemicals in In Vitro Cell-Based Bioassays. Chem Res Toxicol. 2020;33(7):1845-1854. doi:10.1021/acs.chemrestox.0c00067

  4. Müller ME, Werneburg M, Glaser C, et al. Influence of Emission Sources and Tributaries on the Spatial and Temporal Patterns of Micropollutant Mixtures and Associated Effects in a Small River. Environ Toxicol Chem. 2020;39(7):1382-1391. doi:10.1002/etc.4726

  5. Fischer FC, Abele C, Henneberger L, et al. Cellular Metabolism in High-Throughput In Vitro Reporter Gene Assays and Implications for the Quantitative In Vitro-In VivoExtrapolation. Chem Res Toxicol. 2020;33(7):1770-1779. doi:10.1021/acs.chemrestox.0c00037


This guy hasn’t plasmids anything yet.

Hot plasmids


This guy has no following anyone.

Popular Cloud Scientists

Cloud Scientists

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2024 MolecularCloud